Aggressiveness and outcome of papillary thyroid carcinoma (PTC) versus microcarcinoma (PMC): A mono-institutional experience

Journal of Surgical Oncology

Volumn 95, Issue 7, 2007, Pages 555-560

  Cappelli, C ^a   Castellano, M ^a   Braga, M ^b   Gandossi, E ^a   Pirola, I ^a   De Martino, E ^a   Agosti, B ^a   Agabiti Rosei, E ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Spedali Civili of Brescia   (Italy)

Author keywords

Microcarcinoma; Thyroid cancer; Ultrasound

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; THYROID CARCINOMA; UTERINE CERVIX CARCINOMA; VASCULARIZATION; ADJUVANT THERAPY; CANCER STAGING; ECHOGRAPHY; LYMPH NODE; LYMPH NODE METASTASIS; METASTASIS; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEEDLE BIOPSY; PAPILLARY CARCINOMA; PATHOLOGY; THYROID GLAND; THYROID TUMOR; THYROIDECTOMY; TREATMENT OUTCOME;

RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

ADULT; BIOPSY, FINE-NEEDLE; CARCINOMA, PAPILLARY; FEMALE; HUMANS; IODINE RADIOISOTOPES; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; RADIOPHARMACEUTICALS; RADIOTHERAPY, ADJUVANT; THYROID GLAND; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 34347377722     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20746     Document Type: Article

References (39)

1. Jemal A, Murray T, Ward E, et al.: Cancer statistics. Cancer 2005; 70:10-30.
2. Mazzaferri EL, Jhiang SM: Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418-428.
3. Hundahl SA, Fleming ID, Fremgen AM, et al.: A national cancer data base report on 53.856 cases of thyroid carcinoma treated in the US, 1985-1995. Cancer 1998;83:2638-2648.
4. Figge J: Thyroid cancer: A comprehensive guide to clinical management. Wartofsky L, editor. Humana Press, 1999: pp 77-83.
5. Sampson RJ, Key CR, Buncher CR: Thyroid carcinoma in Hiroshima and Nagasaki: Prevalence of thyroid carcinoma autopsy. J Am Med Assoc 1969;209:65-70.
6. Rossi RL, Cady B, Silverman ML, et al: Current results of conservative surgery for differentiated thyroid carcinoma. World J Surg 1986;10:612-622.
7. Bramley MD, Harrison BJ: Papillary microcarcinoma of the thyroid gland. Br J Surg 1996;83:1674-1683.
8. Hay ID, Grant CS, van Heerden JA, et al.: Papillary thyroid microcarcinoma: A study of 535 cases observed in a 50-year period. Surgery 1994;112:1139-1147.
9. Rodriguez JM, Moreno A, Parrilla P, et al.: Papillary microcarcinoma: Clinical study and prognosis. Eur J Surg 1997;163: 255-259.
10. Cappelli C, Pirola I, Cumetti D, et al.: Is the anteroposterior and transverse diameter ratio of nonpalpable thyroid nodules a sonographic criteria for recommending fine-needle aspiration cytology? Clin Endocrinol 2005;63:689-693.
11. Baudin E, Travagli JP, Ropers J, et al.: Microcarcinoma of the thyroid gland. The Gustave-Roussy Institute experience. Cancer 1998;85:553-559.
12. Lin JD, Chao TC, Wenig HF, et al.: Clinical presentations and treatment of 74 occult thyroid carcinoma. Comparison with non occult thyroid carcinoma in Taiwan. Am J Clin Oncol 1996;504-508.
13. Yamashita H, Noguchi S, Murakami N, et al.: Extracapsular invasion of lymph node metastasis. A good indicator of disease recurrence and poor prognosis in patients with thyroid microcarcinoma. Cancer 1999;86:842-849.
14. Lupoli G, Vitale G, Caraglia M: Familial papillary thyroid microcarcinoma: A new clinical entity. Lancet 1999;353:637-639.
15. Akslen LA, Myking AO, Salvensen H, et al.: Prognostic importance of various clinicopathological features in papillary thyroid carcinoma. Eur J Cancer 1992;29:44-51.
16. Akslen LA, Li Volsi VA: Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma. Cancer 2000;88:1902-1908.
17. Mazzaferri E: An overview of the management of papillary and follicular thyroid carcinoma. Thyroid 1999;9:421-427.
18. Sugg SLZL, Rosen IB, Freeman JL, et al.: RET/PTC-1, -2 and -3 oncogene rearrangements in human thyroid carcinomas: Implications for metastatic potential? J Clin Endocrinol Metab 1996; 81:3360-3365.
19. Thomas GA, Bunnell H, Cook LLA, et al.: High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: A strong correlation between RET/PTC3 and solid follicular variant. J Clin Endocrinol Metab 1999;84:4232-4238.
20. AJCC cancer staging manual, 6th edition. New York: Springer-verlag, 2002.
21. Cappelli C, Castellano M, Pirola I, et al.: Thyroid nodule shape suggests malignancy. Eur J Endocrinol 2006;155:27-31.
22. Cappelli C, Tironi A, Mattanza C, et al.: Cost-effectiveness of fine-needle aspiration cytology of thyroid nodules with intranodular vascular pattern using two different needle types. Endocr Pathol 2005;16:349-354.
23. Mandel SJ: A 64-year old woman with a thyroid nodule. JAMA 2004;292:2632-2642.
24. Papini E, et al.: Risk of malignancy in nonpalpable thyroid nodules: Predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 2002;87:1941-1946.
25. Mandel SJ: What are the ultrasound criteria for fine-needle aspiration cytology of non palpable thyroid nodules? Nature clinical practice 2006;2:372-373.
26. Cardis E, Hove G, Ron E, et al.: Cancer consequences of the Chernobyl accident: 20 years on. J Radiol Prot 2006;26:127-140.
27. Wang C, Crapo L: The epidemiology of thyroid disease and the implications for screening. Endocrinol Metab Clin North Am 1997;26:189-218.
28. Martinez-Tello FJ, Martinez-Cabruja R, Fernandez-Martin J, et al.: Occult carcinoma of the thyroid. A systematic autopsy study from Spain of two series performed with two different methods. Cancer 1993;71:4022-4029.
29. Pelizzo MR, Boschin IM, Toniato A, et al.: Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): A mono-institutional 12-year experience. Nucl Med Commun 2004;25:547-552.
30. Ito Y, Ubruno T, Nakano K, et al.: An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 2003;13:381-387.
31. Orsenigo E, Beretta E, Fiacco E, et al.: Management of papillary microcarcinoma of the thyroid gland. Eur J Surg Oncol 2004; 30:1104-1106.
32. Pellegriti G, Scollo C, Lumera G, et al.: Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: Study of 299 cases. J Clin Endocrinol Metab 2004;89: 3713-3720.
33. Iida F, Yonekura M, Miyakawa M: Study of intraglandular dissemination of thyroid cancer. Cancer 1969;24:764-771.
34. Katoh R, Sasaki J, Kurihara H, et al.: Multiple thyroid involvement (intraglandular metastasis) in papillary thyroid carcinoma: A clinicopathologic study of 105 consecutive patients. Cancer 1992;70:1585-1590.
35. Shattuck TM, Westra WH, Ladenson PW, et al.: Indipendent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma. N Engl Med 2005;352:2406-2412.
36. Sherman SI: Thyroid carcinoma. Lancet 2003;361:501-511.
37. Lundgren CI, Hall P, Dickman PW, et al.: Clinically significant prognostic factors for differentiated thyroid carcinoma: A population-based, nested case-control study. Cancer 2006;106: 524-531.
38. Laroche M, Brousset P, Ludot I, et al.: Increased vascularization in myeloma. Eur J Haematol 2001;66:89-93.
39. Delorme S: Evaluating tumor vascularization with Doppler ultrasound. Radiol 1998;38:335-343.